Clinical Trials · NCT01879917
Liraglutide in Newly Onset Type 1 Diabetes.
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- Hvidovre University Hospital
- Enrollment
- 65
- Start date
- Feb 2014
- Locations
- 1 site, Denmark
- Primary endpoint
- Beta-cell function